These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 32902029)

  • 1. Polypharmacy and psychotropic polypharmacy in adults with intellectual disability: a cross-sectional total population study.
    McMahon M; Hatton C; Bowring DL
    J Intellect Disabil Res; 2020 Nov; 64(11):834-851. PubMed ID: 32902029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics and the trajectory of psychotropic medication use in general and antipsychotics in particular among adults with an intellectual disability who exhibit aggressive behaviour.
    Deb S; Unwin G; Deb T
    J Intellect Disabil Res; 2015 Jan; 59(1):11-25. PubMed ID: 24450426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence, patterns and factors associated with psychotropic use in older adults with intellectual disabilities in Ireland.
    O'Dwyer M; Peklar J; Mulryan N; McCallion P; McCarron M; Henman MC
    J Intellect Disabil Res; 2017 Oct; 61(10):969-983. PubMed ID: 28639298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of psychotropic medication use and association with challenging behaviour in adults with an intellectual disability. A total population study.
    Bowring DL; Totsika V; Hastings RP; Toogood S; McMahon M
    J Intellect Disabil Res; 2017 Jun; 61(6):604-617. PubMed ID: 28090687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychotropic medication use in people living with severe and persistent mental illness in the Australian community: a cross-sectional study.
    Hu J; McMillan SS; Theodoros T; Collins JC; El-Den S; O'Reilly CL; Wheeler AJ
    BMC Psychiatry; 2022 Nov; 22(1):705. PubMed ID: 36380352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of Psychotropic Medication Use and Psychotropic Polypharmacy in Autistic Adults With or Without Intellectual Disability.
    Yoshida K; Lunsky Y; Müller DJ; Desarkar P
    J Autism Dev Disord; 2024 Jan; ():. PubMed ID: 38219270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prevalence of potential drug-drug interactions in adults with intellectual disability.
    McMahon M; Hatton C; Bowring DL; Hardy C; Preston NJ
    J Intellect Disabil Res; 2021 Oct; 65(10):930-940. PubMed ID: 33988262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychotropic medication use for adults and older adults with intellectual disability; selective review, recommendations and future directions.
    Deutsch SI; Burket JA
    Prog Neuropsychopharmacol Biol Psychiatry; 2021 Jan; 104():110017. PubMed ID: 32544599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of Psychotropic Polypharmacy Among Outpatients With Psychiatric Disorders and Intellectual Disability.
    Lunsky Y; Modi M
    Psychiatr Serv; 2018 Feb; 69(2):242-246. PubMed ID: 29089006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of psychotropic medications in adults with intellectual disability: a scoping review.
    Costello A; Hudson E; Morrissey S; Sharma D; Kelly D; Doody O
    Ann Med; 2022 Dec; 54(1):2486-2499. PubMed ID: 36120887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multimorbidity and psychotropic polypharmacy among participants with autism spectrum disorder with intellectual disability.
    Espadas C; Ballester P; Londoño AC; Almenara S; Aguilar V; Belda C; Pérez E; Peiró AM
    Psychiatry Res; 2020 Oct; 292():113321. PubMed ID: 32738553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pediatric Psychotropic Polypharmacy: An Evaluation of the Correlates and Prevalence Across Assessment Cycles in the National Health and Nutrition Examination Survey.
    Bilsky S; Blumenthal H; Ramadan B; Lewis S; Leen-Feldner EW
    J Child Adolesc Psychopharmacol; 2022 Oct; 32(8):416-425. PubMed ID: 36074100
    [No Abstract]   [Full Text] [Related]  

  • 13. Is higher psychotropic medication burden associated with involuntary treatment under the Mental Health Act? A four-year Australian cohort study.
    Wheeler AJ; Hu J; Profitt C; McMillan SS; Theodoros T
    BMC Psychiatry; 2020 Jun; 20(1):294. PubMed ID: 32527250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Problem behaviours and psychotropic medication use in intellectual disability: a multinational cross-sectional survey.
    Perry BI; Cooray SE; Mendis J; Purandare K; Wijeratne A; Manjubhashini S; Dasari M; Esan F; Gunaratna I; Naseem RA; Hoare S; Chester V; Roy A; Devapriam J; Alexander R; Kwok HF
    J Intellect Disabil Res; 2018 Feb; 62(2):140-149. PubMed ID: 29349928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors associated with polypharmacy and excessive polypharmacy in older people with intellectual disability differ from the general population: a cross-sectional observational nationwide study.
    O'Dwyer M; Peklar J; McCallion P; McCarron M; Henman MC
    BMJ Open; 2016 Apr; 6(4):e010505. PubMed ID: 27044582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and patterns of anti-epileptic medication prescribing in the treatment of epilepsy in older adults with intellectual disabilities.
    O'Dwyer M; Peklar J; Mulryan N; McCallion P; McCarron M; Henman MC
    J Intellect Disabil Res; 2018 Mar; 62(3):245-261. PubMed ID: 29314463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of Mental Health Service Use During the Transition to Adulthood Among Autistic Adolescents and Young Adults.
    Davis SA; Annis IE; Hughes PM; DeJong NA; Christian RB; Ruble LA; Thomas KC
    Autism Adulthood; 2023 Dec; 5(4):366-373. PubMed ID: 38116058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and factors associated with polypharmacy in Victorian adults with intellectual disability.
    Haider SI; Ansari Z; Vaughan L; Matters H; Emerson E
    Res Dev Disabil; 2014 Nov; 35(11):3071-80. PubMed ID: 25129201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychotropic medicines' prevalence, patterns and effects on cognitive and physical function in older adults with intellectual disability in Ireland: longitudinal cohort study, 2009-2020.
    Odalović M; Gorman A; Paul A; McCallion P; Burke É; MacLachlan M; McCarron M; Henman MC; Moran M; O'Connell J; Walsh M; Shankar R; Ryan C; O'Dwyer M
    BJPsych Open; 2024 Feb; 10(2):e39. PubMed ID: 38297892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of Polypharmacy and Inappropriate Medication in Adults With Intellectual Disabilities in a Hospital Setting in Switzerland.
    Lonchampt S; Gerber F; Aubry JM; Desmeules J; Kosel M; Besson M
    Front Psychiatry; 2021; 12():614825. PubMed ID: 34248693
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.